Onera Health is redefining the landscape of sleep diagnostics with its innovative, patch-based home polysomnography (PSG) solution, which is set to feature prominently at the SLEEP 2025 conference. The company’s Type II PSG system, designed for patient self-application, provides a comprehensive sleep study experience outside traditional clinical settings. By enabling full-spectrum sleep diagnostics at home—without the need for technician-led setup or complex equipment—Onera’s system addresses the long-standing barriers of access, convenience, and clinical scalability in sleep medicine.
The clinical relevance and practical utility of Onera’s technology will be highlighted through four scientific poster presentations and a dedicated symposium during the event. These presentations include validation results, real-world usability data, and patient feedback across U.S. and European deployments. Key studies cover areas such as disease assessment in PAP-intolerant patients, signal quality comparisons, system validation, and patient perception. Of particular note is the study titled "Validation of a Novel Patch-Based Type II Polysomnography System", which supports the solution's clinical accuracy and diagnostic viability. The symposium “Expanding Access, Enhancing Outcomes” will further explore how home PSG can alleviate infrastructure constraints and improve diagnostic pathways for undiagnosed patients.
With growing awareness of sleep health and a shortage of sleep labs and specialists, the importance of scalable, accurate home diagnostics has never been greater. Onera’s solution delivers on this need, enabling earlier interventions and broader screening for sleep disorders. Its continued validation and adoption stand to not only enhance patient outcomes but also reduce healthcare costs and improve clinician workflow. As demonstrated by its presence at SLEEP 2025, Onera Health is leading a pivotal shift in how sleep care is delivered—bringing clinical-grade diagnostics directly to the patient’s home.
MedTech Spectrum's Summary
Expanded Access to Diagnostics: Onera Health’s patch-based home polysomnography system enables comprehensive sleep testing at home, addressing critical limitations such as lab capacity shortages and limited access to sleep specialists.
Validated Clinical Performance: Multiple studies presented at SLEEP 2025 validate the system’s diagnostic accuracy, signal quality, and patient acceptance across real-world settings in the U.S. and Europe.
Transforming Sleep Medicine: By simplifying and scaling sleep diagnostics, Onera's solution has the potential to reshape care pathways, support earlier intervention for undiagnosed patients, and reduce the burden on traditional healthcare infrastructure.
